Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
19:11
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

52nd ERA-EDTA Congress

 

28-31 May 2015 London
FAQs
   
Discussion forum - 52nd ERA-EDTA Congress
    Topic - H) Clinical Nephrology, primary and secondary glomerulonephritis.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 178
Visits: 27
Title: PODOCYTURIA IN FABRY DISEASE IS ELEVATED IN UNTREATED VS TREATED ADULT PATIENTS AND DOES NOT CORRELATE WITH PROTEINURIA OR RENAL FUNCTION
Authors: HERNAN TRIMARCHI , CANZONIERI R, SCHIEL A, POLITEI J, ANDREWS J, FORRESTER M, ALONSO M, LOMBI F, POMERANZ V, KARL A, RENGEL T, MURYAN A, ZOTTA E
Centre: 1. HOSPITAL BRITANICO DE BUENOS AIRES, 2. FESEN, 3. FACULTAD DE MEDICINA UBA

You must be registered to reply or comment.

PODOCYTURIA IN FABRY DISEASE IS ELEVATED IN UNTREATED VS TREATED ADULT PATIENTS AND DOES NOT CORRELATE WITH PROTEINURIA OR RENAL FUNCTION

HERNAN TRIMARCHI
Thread initiator
Subspeciality
Reg: 5/2/2015 10:42:00 PM

Comment# 1

THERAPY WITH AGALASIDASE &946; 1 MG/KG EOW MAY PROTECT AGAINST IRREVERSIBLE PODOCYTE LOSS AND MAY PRESERVE RENAL FUNCTION. HIGHER LEVELS OF PROTEINURIA IN TREATED PATIENTS MAY INDICATE THE INITIATION OF THERAPY AT ADVANCED STAGES OF THE DISEASE. PODOCYTURIA COULD BE EMPLOYED AS A BIOMARKER TO START THERAPY OR TO ASSESS RESPONSE TO THERAPY, BUT NEEDS TO BE VALIDATED

Comment added on 5/2/2015 10:42:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 625
Visits: 3858
Title: IS 4 CITRATE AN EFFECTIVE TOOL AS A CATHETER LOCKING SOLUTION?
Authors: Joao Fazendeiro Matos ,
Centre: Fresenius Medical Care | NephroCare Portugal

Poster most viewed in this topic
Poster: 112
Visits: 173
Title: THE PROTEASOME TO IMMUNOPROTEASOME SWITCH IN IGA NEPHROPATHY AND ITS GENETIC CONTROL: A POST-VALIGA EUROPEAN RESEARCH STUDY.
Authors: LICIA PERUZZi ,
Centre: AOU Cittą della Salute e della Scienza di Torino PO OIRM


 






PosterSessionOnline
Logo Draft
 
Logo Cert